Immunotherapy Pioneer James Allison Has Unfinished Business with Cancer
by from MIT Technology Review on (#2M3WE)
Why do most patients fail to respond to the newest cures?Why do most patients fail to respond to the newest cures?Why do most patients fail to respond to the newest cures?External Content
| Source | RSS or Atom Feed |
| Feed Location | https://www.technologyreview.com/topnews.rss?from=feedstr |
| Feed Title | MIT Technology Review |
| Feed Link | https://www.technologyreview.com/ |
| Reply | 0 comments |